Belotti, Daniela <br/><br/>
Full GMP-compliant validation of bone marrow-derived human CD133(+) cells as advanced therapy medicinal product for refractory ischemic cardiomyopathy.  [electronic resource] 

 -  BioMed research international  2015 
 - 473159 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study 
<br/><br/><label>ISSN: </label>2314-6141 
<br/><br/><label>Standard No.: </label>10.1155/2015/473159  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AC133 Antigen<br/>Animals<br/>Antigens, CD--metabolism<br/>Bone Marrow Cells--cytology<br/>Bone Marrow Transplantation--standards<br/>Cardiomyopathies--etiology<br/>Device Approval--standards<br/>Europe<br/>Glycoproteins--metabolism<br/>Guideline Adherence<br/>Humans<br/>Myocardial Ischemia--complications<br/>Peptides--metabolism<br/>Practice Guidelines as Topic<br/>Stem Cell Transplantation--standards<br/>Stem Cells